Data from Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival

MLA

Selvarangan Ponnazhagan, et al. Data from Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-Term Survival. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1535-7163.c.6543574.v1.

APA

Selvarangan Ponnazhagan, Champion Deivanayagam, Joshua L. Mieher, Jessy S. Deshane, Yong Wang, Anna G. Sorace, Yun Lu, Reading Ashton, Jonathan A. Hensel, Vinayak Khattar, & Hong Wang. (2023). Data from Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival. https://doi.org/10.1158/1535-7163.c.6543574.v1

Chicago

Selvarangan Ponnazhagan, Champion Deivanayagam, Joshua L. Mieher, Jessy S. Deshane, Yong Wang, Anna G. Sorace, Yun Lu, et al. 2023. “Data from Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-Term Survival,” April. doi:10.1158/1535-7163.c.6543574.v1.